Atlas Trials

Toxicity, Drug

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Toxicity, Drug

RecordFirmDate
Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy (NCT06558084)Ain Shams University2022-07-06
Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma (NCT05355168)Anhui Provincial Hospital2021-11-01
Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma (NCT04824352)Peking University People's Hospital2021-04-01
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma (NCT04690231)Peking University People's Hospital2020-12-01
Observation Study of the Pharmacokinetics of Adductor Canal Block (NCT04916392)The University of Hong Kong2020-09-01
Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning (NCT04499885)Sherief Abd-Elsalam2020-06-01
Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma (NCT04351308)Peking University People's Hospital2020-05-01
Apatinib for Inoperable Advanced Chondrosarcoma (NCT04260113)Peking University People's Hospital2019-10-01
TIL and Anti-PD1 in Metastatic Melanoma (NCT03638375)Leiden University2018-07-31
Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials (NCT02719002)Fondation Ophtalmologique Adolphe de Rothschild2016-08-26

Track Toxicity, Drug automatically

Every clearance here is in the API, with alerts when new ones post.